TAKING
CARE OF BUSINESS
27th annual Convocation
addresses corporate scandals, bioinformatics
Left
to right:
Lynn
A. Clarke, John M. Curran, Garry M. Graber, Paul Gonson, Mark D. Rasch,
Robert J. Genco, Shubha Ghosh, Jeffrey Skolnick and Hon. Joseph G. Makowski
“Ethics
for the Computer Age: Corporate Accountability and Bioinformatics” was
the cutting-edge title of the 27th annual Convocation of the UB Law
Alumni Association – coming off a year of corporate scandals and celebrating
the possibilities of the emerging biomedical field of bioinformatics.
Held
Nov. 2, 2002, in the Hyatt Regency Buffalo, the Convocation featured
UB Law-affiliated expects in many aspects of both corporate topics.
First
at the podium was Garry M. Graber ’78, who practices bankruptcy and
corporate restructuring law at the Buffalo firm Hodgson Russ. Graber
spoke of “the basics: how the leaders of our business community are
supposed to act, and how we are supposed to advise them.”
For
solvent entities, he said, there are two basic requirements: the duty
of care and the duty of loyalty. The duty of care, he said, “requires
officers and directors to run their entities with some degree of care
and not be negligent. It is an ordinary prudent person standard.
“The
duty of loyalty is more often violated. It says that directors and officers
must put the interest of the corporation first, ahead of their own.”
When
a corporation becomes insolvent, Graber said, special rules apply: The
duties of the firm’s officers and directors are expanded to include
the creditors. “There are very few cases where you have to look out
for the interests of the creditors first,” Graber said. “They and the
corporation join together in a community of interest.”
Paul
Gonson ’54, a former chief appellate lawyer for the federal Securities
and Exchange Commission, spoke next about new rules that agency is developing
for corporate attorneys. This action, he said, comes in “response to
the perception that many lawyers involved in the scandals we have heard
about were quiescent: that they didn’t do enough to mitigate the unfortunate
financial consequences and pensioners in these enormous financial catastrophes
– that they engaged in what is sometimes referred to as deliberate or
willful blindness.”
The
Sarbanes-Oxley Act of 2002, Gonson said, includes an amendment, known
as Section 307, that deals with the conduct of corporate lawyers. “This
section,” he said, “has no legislative history or any statements from
the sponsors at all, yet it is extremely broadly worded.” He quoted
Sen. John Edwards during debate on the amendment: “Sometimes lawyers
forget that they owe their loyalty to the corporation and the shareholders
and instead decide they are working for the chief executive officer
or the chief operating officer who hired them. They get to thinking
that playing squash with the CEO every week is more important than keeping
faith with the shareholders every day. So the lawyers may not view their
duty to say to their pal the CEO, ‘No, you cannot break the law.’
“This
is such a basic concept that it is alarming to see statements like that
work their way into legislation.”
John
M. Curran ’84 gave “a New York litigator’s perspective on electronic
discovery,” noting that 93 percent of new information is created in
digital format.
In
2001, he said, U.S. businesses generated more than 1.4 billion e-mails,
and such traffic is only going to increase. “E-discovery is here to
stay,” he said, “and it is going to get bigger, and the sooner we get
comfortable with it, the better litigators we are going to be and the
better we can serve our clients.”
Electronic
traffic, though, raises issues of confidentiality, Curran said. “We
all need to start thinking, because it is here to stay,” he said. “What
about your PDAs? What about your cell phones? The bar associations are
starting to talk about the confidentiality of cell phone conversations.
You had darn well better have digital.”
Good
client representation, he said, “means knowing what kind of electronic
resources are out there. Technological dysfunction can no longer be
a source of pride.”
Mark
D. Rasch ’83, an internationally known expert in cyberlaw and computer
crime, also spoke about the discovery process in detail. “When you are
seeking discovery of electronic records,” he advised, “the first thing
you want to do is write a definition of ‘document.’ Because if you do
not ask for it, it will not be produced. Think about things like, what
about telecommuters? The guy is at home, he is not on the network all
the time, and he has documents in his possession. What about a personal
computer with corporate files on it? Include in your definition of ‘document’
deleted files.
“Two
basic rules is that delete doesn’t and restore won’t. By definition,
when you write an e-mail there are already two copies, because you’re
writing to someone else. I have learned from experience that the four
worst words a lawyer can hear is, ‘Oh, by the way ...’ ”
Also
on the dais as an interlocutor was Hon. Joseph G. Makowski ’79, a State
Supreme Court justice and former commercial litigator.
The
Convocation’s second half celebrated the innovative biomedical science
of bioinformatics, including the newly established Center of Excellence
in Bioinformatics at UB. The director of that center, Jeffrey Skolnick,
gave an overview of the science involved and its commercial potential.
“What
the sequencing of the human genome has done is provide a parts list
for proteins,” Skolnick said. “Of these 35,000 or so proteins, we know
something about the function of about half.
“Ultimately
what you would like to be able to do is to have personalized medicine.
The problem is that people are different in very, very subtle ways.
What we would like to be able to do is to understand the differences
between human beings and target medicines to individuals. This is not
going to happen tomorrow. It will happen in stages.”
Skolnick
compared the genome information to parts of a car. “I have 35,000 parts,”
he said, “and at least 350,000 interactions and ways that cells can
be modified. Can we figure out which proteins are responsible for specific
diseases, and how we can regulate them?”
For
commercial applications, Skolnick said, speed is a prime mover. “Currently,”
he said, “it takes eight to 10 years, and anywhere from half a billion
to a billion dollars, to design a drug. Perhaps we can do a little bit
better.”
UB
Vice Provost Robert J. Genco, head of UB’s office of science, technology
transfer and economic outreach, spoke next about maximizing the return
on technology created by the University’s scientists.
“What
is happening at the University is very exciting, and we need to be proactive
in this area,” Genco said. “Once a piece of intellectual property is
developed, we have to act in a nimble fashion. In the last six months,
we have evaluated 53 total technologies and decided to patent or copyright
37. Of those 37 we decided to go ahead with, eight of them seem to be
start-up possibilities.” One example, he said, is a better compound
for photodynamic therapy for cancer.
“We
have wonderful opportunities because of the research and collaborations
that we have here,” Genco said, “but more importantly, the community
is speaking with one voice. The state, federal and city governments
– they all want this to happen. I believe this is putting down deep
roots. I think of this as a generational effort.”
Finally,
Law School Associate Professor Shubha Ghosh, a specialist in intellectual
property law, spoke of the legal implications of bioinformatics.
“This
whole area of intellectual property and securities will become very
important,” Ghosh said. Because of a shift in policy, he said, government-funded
research can now be patented, leading to commercial applications: “Academics
can now become sort of independent contractors.”
Ghosh
discussed three principles of intellectual property law that come into
play: the idea that “building-block ideas or fundamental principles”
can be owned, such as computer programs; the understanding that copyright
and patent law benefit the public by allowing property rights eventually
to enter the public domain; and the idea that “things in nature cannot
be owned as intellectual property. This has led to some very interesting
questions about what is man-made and what is natural.”
|